Skip to content
10-Q

Quarterly Report

Ventyx Biosciences, Inc.

0001193125-25-269517

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 71.36M sh
Shares Diluted Q3 2025 · Sep 30, 2025 71.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 71.21M sh
Shares Diluted Q3 2025 · Sep 30, 2024 70.67M sh
Shares Diluted Q3 2025 · Sep 30, 2024 67.69M sh
Capex Q3 2025 · Sep 30, 2025 $108K
Capex Q3 2025 · Sep 30, 2024 $235K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$64.5M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$107.62M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $31.97M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $27.26M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $61.77M
Stockholders Equity Q3 2025 · Sep 30, 2025 $191.36M
Stockholders Equity Q3 2025 · Jun 30, 2025 $209.38M
Stockholders Equity Q3 2025 · Mar 31, 2025 $231.63M
Stockholders Equity Q3 2025 · Dec 31, 2024 $254.05M
Stockholders Equity Q3 2025 · Sep 30, 2024 $278.77M
Stockholders Equity Q3 2025 · Jun 30, 2024 $280.8M
Stockholders Equity Q3 2025 · Mar 31, 2024 $307M
Stockholders Equity Q3 2025 · Dec 31, 2023 $243.92M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.26M
Current Liabilities Q3 2025 · Dec 31, 2024 $12.78M
Total Liabilities Q3 2025 · Sep 30, 2025 $20.1M
Total Liabilities Q3 2025 · Dec 31, 2024 $22.52M
Current Assets Q3 2025 · Sep 30, 2025 $201.09M
Current Assets Q3 2025 · Dec 31, 2024 $229.63M
Total Assets Q3 2025 · Sep 30, 2025 $211.47M
Total Assets Q3 2025 · Dec 31, 2024 $276.56M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.32
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.08
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.56
Eps Diluted Q3 2025 · Jun 30, 2024 −$0.50
Eps Basic Q3 2025 · Sep 30, 2025 −$0.32
Eps Basic Q3 2025 · Sep 30, 2025 −$1.08
Eps Basic Q3 2025 · Sep 30, 2024 −$0.50
Eps Basic Q3 2025 · Sep 30, 2024 −$1.56
Eps Basic Q3 2025 · Jun 30, 2024 −$0.50
Sga Expense Q3 2025 · Sep 30, 2025 $7.17M
Sga Expense Q3 2025 · Sep 30, 2025 $21.43M
Sga Expense Q3 2025 · Sep 30, 2024 $7.92M
Sga Expense Q3 2025 · Sep 30, 2024 $23.85M
Rd Expense Q3 2025 · Sep 30, 2025 $17.71M
Rd Expense Q3 2025 · Sep 30, 2025 $62.87M
Rd Expense Q3 2025 · Sep 30, 2024 $30.63M
Rd Expense Q3 2025 · Sep 30, 2024 $92.18M
Net Income Q3 2025 · Sep 30, 2025 −$22.83M
Net Income Q3 2025 · Sep 30, 2025 −$77.26M
Net Income Q3 2025 · Jun 30, 2025 −$26.99M
Net Income Q3 2025 · Mar 31, 2025 −$27.44M
Net Income Q3 2025 · Sep 30, 2024 −$35.25M
Net Income Q3 2025 · Sep 30, 2024 −$105.77M
Net Income Q3 2025 · Jun 30, 2024 −$31.95M
Net Income Q3 2025 · Mar 31, 2024 −$38.57M
Operating Income Q3 2025 · Sep 30, 2025 −$24.87M
Operating Income Q3 2025 · Sep 30, 2025 −$84.3M
Operating Income Q3 2025 · Sep 30, 2024 −$38.55M
Operating Income Q3 2025 · Sep 30, 2024 −$116.03M